Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy.

By E. Messing, J. Manola, Jorge Yao, M. Kiernan, D. Crawford, G. Wilding, P. A. di'Santagnese, D. Trump. The Lancet Oncology, 2006

924 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Urology

View Paper: https://www.semanticscholar.org/paper/74d050f2be6d0ee38efbd94497d7fa62b720bd9e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pulmonary and Respiratory Medicine

1. A. Heidenreich
2. Michel Bolla
3. N. Mottet
4. J. Bellmunt
5. V. Matveev
6. Steven Joniau
7. F. Zattoni
8. Thomas Wiegel

Citations in the corpus

• Guidelines on Prostate Cancer (2013, background): “The correlation between serum PSA and bone scintigraphy in patients with newly diagnosed untreated PCa has been further investigated (70-74).”
• EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. (2024, positive): “In men with pN+ PCa, early adjuvant androgen deprivation therapy (ADT) was shown to achieve a 10-yr CSS rate of 80% [95].”
• EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. (2017, positive): “In men with pN+ PCa, early adjuvant androgendeprivation therapy (ADT) was shown to achieve a 10-yr CSS rate of 80% [51].”
• Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. (2007, result): “9 years.(28) Seventeen of 47 men who received immediate ADT died compared with 28 of 51 men who received ADT at disease progression (HR, 1.”
• EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. (2011, background): “Although the only prospective randomised trial demonstrated a significant survival advantage for immediate ADT in node-positive disease [63], it has to be acknowledged that most patients had gross nodal disease and that 70% also had positive margins and/or SVI.”
• EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. (2020, methodology): “In men with pN + PCa, early adjuvant androgen deprivation therapy (ADT) was shown to achieve a 10-yr CSS rate of 80% [114].”
• EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. (2014, background): “In patients who prove to be pN+ after RP, early ADT has been shown to significantly improve cancer-specific survival and overall survival in a prospective randomized trial [82].”